Home » Newsletters » BioWorld Science

BioWorld Science

April 10, 2012

View Archived Issues

New agent for liver disorders patented by Norgine Europe

First-in-class cancer immunotherapy well tolerated in phase I trial

Novel solute carrier family 22 member 12 inhibitors designed

Bristol-Myers Squibb presents novel HIV integrase inhibitors

Taiho Pharmaceutical reports new H-PGDS inhibitors

New protein kinase inhibitors disclosed by Bayer Schering Pharma

Cell-based gene therapy is well tolerated in phase I study

CSA-131 active against Gram-negative bacteria

ARMOR1 trial assesses safety of galeterone in prostate cancer

Amgen presents first preclinical data on novel anticancer drug

New data support potential of Cell-in-a-Box technology

Novel anticancer nanomedicine shows promise in clinical trial

DARPin-based VEGF inhibitor completes phase IIa trial

Muscular Dystrophy Association awards grant to Catabasis Pharmaceuticals

Sanofi and Alfresa Pharma launch vigabatrin collaboration

Stroke biomarker license granted to Randox

Spectrum Pharmaceuticals announces acquisition

Phase III results reported for apaziquone

Amorfix establishes proof of concept for lead tumor-specific antibody

FDA approves adjunct radioactive diagnostic for Alzheimer's disease

FDA advisory committee issues recommendation on Astellas' mirabegron

Preclinical studies demonstrate small molecule's efficacy to treat anterior uveitis

Phase I/II trial begins evaluating Syndax's entinostat with lapatinib in metastatic breast cancer

Winston Pharmaceuticals receives grant to develop civamide nasal solution

Pacira Pharmaceuticals launches Exparel in U.S.

Next-generation drug-eluting stent approved in Japan to treat coronary artery disease

Pharmos reports promising data from ongoing phase IIa trial of levotofisopam

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...